PMN

ProMIS Neurosciences (PMN)

About ProMIS Neurosciences (PMN)

ProMIS Neurosciences, Inc. engages in the discovery and development of precision medicine solutions for early detection and effective treatment of neurodegenerative diseases. It focuses on the progression of Alzheimer's disease, amyotrophic lateral sclerosis, and Parkinson's disease. The company was founded by Neil Cashman and Vigen Nazarian on January 23, 2004 and is headquartered in Toronto, Canada.

Details

Daily high

$9.42

Daily low

$9.02

Price at open

$9.14

52 Week High

$39.75

52 Week Low

$6.27

Market cap

20.1M

Dividend yield

0.00%

Volume

18,623

Avg. volume

45,038

P/E ratio

-.50

ProMIS Neurosciences News